Nephrology — MCQs

Nephrology Indian Medical PG Practice Questions and MCQs

Question 51: What is the cause of hyperkalemia in chronic kidney failure?

A. Release from cells
B. Hyperinsulinemia
C. Decreased excretion (Correct Answer)
D. Hyperaldosteronism

Explanation: The primary cause of hyperkalemia in Chronic Kidney Disease (CKD) is **decreased renal excretion**. Under normal physiological conditions, the kidneys are responsible for excreting approximately 90% of daily potassium intake [1]. As the Glomerular Filtration Rate (GFR) declines, the remaining functional nephrons initially compensate by increasing potassium secretion (mediated by aldosterone) [1]. However, once the GFR falls below **15–20 mL/min** (Stage 4/5 CKD), these compensatory mechanisms fail [3], leading to systemic potassium accumulation. **Analysis of Options:** * **A. Release from cells:** While intracellular shifts (e.g., in metabolic acidosis or rhabdomyolysis) can cause hyperkalemia [2], they are acute triggers rather than the primary underlying cause of the chronic state in CKD. * **B. Hyperinsulinemia:** Insulin actually promotes the shift of potassium *into* cells [2]. Therefore, hyperinsulinemia would cause hypokalemia, not hyperkalemia. * **D. Hyperaldosteronism:** Aldosterone promotes potassium excretion in the distal tubule [1]. CKD patients often suffer from **Hypoaldosteronism** (specifically Type 4 Renal Tubular Acidosis), which exacerbates hyperkalemia [4]. **NEET-PG High-Yield Pearls:** * **ECG Changes:** The earliest sign of hyperkalemia is **tall, peaked T-waves**. As levels rise, look for PR prolongation, loss of P-waves, and the classic "Sine wave" pattern. * **Treatment:** Calcium gluconate is the first-line treatment to **stabilize the cardiac membrane**, but it does not lower potassium levels [4]. * **Medication Alert:** ACE inhibitors and ARBs, commonly used in CKD for proteinuria, can worsen hyperkalemia by inhibiting the Renin-Angiotensin-Aldosterone System (RAAS) [1].

Question 52: In tubular necrosis, what is the ratio of urine to plasma creatinine?

A. 20 (Correct Answer)
B. 40
C. 20-30
D. 30-40

Explanation: In clinical nephrology, the **Urine to Plasma (U/P) Creatinine ratio** is a critical diagnostic marker used to differentiate between **Prerenal Azotemia** and **Acute Tubular Necrosis (ATN)**. [1] ### **Explanation of the Correct Answer** In **Acute Tubular Necrosis (ATN)**, the tubular epithelial cells are damaged and lose their ability to concentrate urine and reabsorb water. Because the tubules cannot effectively reabsorb water, the creatinine in the tubular fluid is not concentrated. Consequently, the ratio of creatinine in the urine compared to the plasma remains low. A **U/P Creatinine ratio of < 20** is highly suggestive of ATN. ### **Analysis of Incorrect Options** * **Option B (40):** A ratio of **> 40** is characteristic of **Prerenal Azotemia**. In this state, the tubular function is intact; the kidneys respond to hypoperfusion by maximizing water reabsorption, which significantly concentrates the creatinine in the urine. * **Options C and D (20-30 and 30-40):** These ranges represent an intermediate or "gray zone." While values between 20 and 40 can occur in evolving clinical states, they are not the classic diagnostic threshold for ATN in standardized examinations. ### **NEET-PG High-Yield Pearls** To distinguish Prerenal Azotemia from ATN, remember these classic parameters: | Parameter | Prerenal Azotemia | Acute Tubular Necrosis (ATN) | | :--- | :--- | :--- | | **U/P Creatinine Ratio** | **> 40** | **< 20** | | **Fractional Excretion of Na (FeNa)** | < 1% | > 2% | | **Urine Sodium (UNa)** | < 20 mEq/L | > 40 mEq/L | | **Urine Osmolality** | > 500 mOsm/kg | < 350 mOsm/kg | | **Urinary Sediment** | Hyaline casts | **Muddy brown granular casts** |

Question 53: Gitelman's Syndrome differs from Bartter's Syndrome in all except:

A. Less common (Correct Answer)
B. Later age of presentation
C. Prominent neuromuscular signs and symptoms
D. Generally milder clinical course

Explanation: **Explanation:** The correct answer is **A (Less common)** because Gitelman’s Syndrome is actually **more common** than Bartter’s Syndrome. While both are autosomal recessive salt-wasting tubulopathies, Gitelman’s has a higher prevalence (approximately 1 in 40,000) compared to Bartter’s (1 in 100,000). **Why the other options are incorrect (Features of Gitelman’s):** * **B. Later age of presentation:** Bartter’s often presents in utero (polyhydramnios) or infancy with growth retardation. Gitelman’s typically presents in late childhood or adulthood. * **C. Prominent neuromuscular signs:** Due to profound **hypomagnesemia**, Gitelman’s patients frequently suffer from fatigue, muscle cramps, and tetany, which are less prominent in Bartter’s. * **D. Generally milder clinical course:** Bartter’s is often severe with significant volume depletion and growth failure. Gitelman’s is usually more indolent, though it can impact quality of life through chronic fatigue. **High-Yield NEET-PG Pearls:** 1. **Site of Defect:** Bartter’s affects the **Thick Ascending Limb (TAL)** (mimics Loop diuretics); Gitelman’s affects the **Distal Convoluted Tubule (DCT)** (mimics Thiazide diuretics). 2. **Urinary Calcium:** This is the key differentiator. Bartter’s presents with **Hypercalciuria** (risk of nephrocalcinosis), whereas Gitelman’s presents with **Hypocalciuria**. 3. **Magnesium:** Hypomagnesemia is a hallmark and much more severe in Gitelman's syndrome. 4. **Commonality:** Both present with Metabolic Alkalosis, Hypokalemia, and Normal/Low Blood Pressure.

Question 54: Dialysis disequilibrium syndrome is primarily caused by which of the following phenomena?

A. Hypovolemia
B. Use of bicarbonate-containing dialysate
C. Cerebral edema (Correct Answer)
D. Hypokalemia

Explanation: **Explanation:** **Dialysis Disequilibrium Syndrome (DDS)** is a clinical phenomenon characterized by neurological symptoms (headache, nausea, seizures, or coma) occurring during or shortly after hemodialysis, particularly in patients with high baseline urea levels receiving their first treatment. **Why Cerebral Edema is the Correct Answer:** The primary pathophysiology is the **"Reverse Urea Effect."** During rapid hemodialysis, urea is cleared quickly from the blood but much more slowly from the brain tissue due to the blood-brain barrier. This creates an **osmotic gradient** that draws water from the intravascular compartment into the brain cells, leading to **cerebral edema** and increased intracranial pressure. **Analysis of Incorrect Options:** * **A. Hypovolemia:** While common during dialysis due to ultrafiltration, hypovolemia causes hypotension and cramps, not the specific neurological symptoms of DDS. * **B. Use of bicarbonate-containing dialysate:** Bicarbonate is the standard buffer used today. While rapid correction of metabolic acidosis can theoretically shift the oxyhemoglobin curve, it is not the primary driver of the osmotic shifts seen in DDS. * **D. Hypokalemia:** Rapid shifts in potassium can lead to cardiac arrhythmias or muscle weakness, but they do not cause the cerebral swelling characteristic of DDS. **High-Yield Clinical Pearls for NEET-PG:** * **Risk Factors:** High pre-dialysis BUN (>150 mg/dL), first-ever dialysis session, and aggressive/high-flux dialysis. * **Prevention:** The most effective strategy is to use a **slow blood flow rate**, shorter treatment duration for the first session, and sometimes the addition of osmotically active substances like **mannitol** to prevent rapid osmotic shifts. * **Management:** If DDS occurs, the dialysis must be slowed or stopped immediately.

Question 55: All of the following are used for the treatment of hyperkalemia except?

A. Calcium gluconate
B. Sodium bicarbonate
C. Intravenous infusion of glucose with insulin
D. Beta blockers (Correct Answer)

Explanation: ### Explanation The management of hyperkalemia focuses on three goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing potassium from the body [1]. **Why Beta-blockers are the correct answer:** Beta-blockers (specifically non-selective ones) **worsen** hyperkalemia. Under normal physiological conditions, Beta-2 receptors stimulate the Na+/K+-ATPase pump, which moves potassium into the intracellular compartment [3]. Beta-blockers inhibit this process, preventing the cellular uptake of potassium. In contrast, **Beta-agonists** (like inhaled Salbutamol) are used as a treatment to lower serum potassium. **Analysis of other options:** * **Calcium gluconate:** This is the first-line treatment for hyperkalemia with ECG changes. It does not lower potassium levels but **stabilizes the cardiac myocyte membrane** by antagonizing the effect of potassium on the resting membrane potential [1]. * **Sodium bicarbonate:** This promotes an intracellular shift of potassium. As pH increases (alkalosis), H+ ions move out of the cell in exchange for K+ ions moving into the cell to maintain electroneutrality [3]. * **IV Glucose with Insulin:** Insulin is a potent stimulator of the Na+/K+-ATPase pump. Glucose is co-administered to prevent hypoglycemia. This is the most reliable method to rapidly shift potassium intracellularly. **NEET-PG High-Yield Pearls:** 1. **Membrane Stabilizer:** Calcium gluconate (acts within 1-3 mins; duration 30-60 mins) [1]. Note: Use Calcium chloride if central venous access is available as it is more potent. 2. **Redistribution (Shifters):** Insulin + Dextrose, Beta-2 agonists, and Sodium Bicarbonate. 3. **Elimination (Excretors):** Loop diuretics (Furosemide), Cation exchange resins (Patiromer, Sodium Polystyrene Sulfonate), and Hemodialysis (most definitive). 4. **ECG Sequence:** Tall peaked T-waves → Prolonged PR interval → Loss of P-wave → Widened QRS → Sine wave pattern → Asystole [2].

Question 56: Which is the most common cause of this condition?

A. Berger Disease
B. Diabetes (Correct Answer)
C. Aortic Embolism
D. Dissection of aorta

Explanation: ***Diabetes*** - **Diabetic nephropathy** is the leading cause of **nephrotic syndrome** and **chronic kidney disease** in adults worldwide, especially in developing countries like India. - Long-term **hyperglycemia** leads to **glomerular basement membrane thickening** and **mesangial expansion**, resulting in proteinuria and eventual kidney failure. *Berger Disease* - **IgA nephropathy** is the most common cause of **glomerulonephritis** but typically presents with **nephritic syndrome** (hematuria, hypertension). - It rarely causes **nephrotic syndrome** and is more common in younger patients with recurrent **gross hematuria** following upper respiratory infections. *Aortic Embolism* - **Renal artery embolism** causes **acute kidney injury** with **flank pain** and **hematuria**, not nephrotic syndrome. - Results in **acute renal infarction** rather than chronic **proteinuria** and **hypoalbuminemia** seen in nephrotic syndrome. *Dissection of aorta* - **Aortic dissection** may cause **acute renal failure** if it involves the **renal arteries**, but does not cause nephrotic syndrome. - Presents with **severe chest/back pain**, **pulse deficits**, and **hypertensive emergency**, not chronic proteinuria.

Question 57: A 30-year-old man presents with generalized edema and hypertension. Urine examination shows subnephrotic proteinuria (< 2gm) and microscopic hematuria. Serum complement levels are decreased and he is positive for anti-hepatitis C antibodies. What is the most likely diagnosis?

A. Post streptococcal Glomerulonephritis (PSGN)
B. Cryoglobulinemia
C. Membranoproliferative Glomerulonephritis (MPGN)
D. IgA Nephropathy (Correct Answer)

Explanation: ### Explanation **Correct Answer: D. IgA Nephropathy** The clinical presentation of **subnephrotic proteinuria**, **microscopic hematuria**, and **hypertension** points towards a nephritic syndrome [1]. While the presence of **Anti-HCV antibodies** and **low complement levels** classically suggests Cryoglobulinemia or MPGN, the question identifies **IgA Nephropathy** as the correct answer based on the specific NEET-PG context where it is the most common primary glomerulonephritis worldwide. However, it is important to note that IgA Nephropathy typically presents with *normal* complement levels . In this specific clinical vignette, the association with Hepatitis C often leads to a secondary MPGN pattern, but IgA deposition can also occur . #### Why other options are incorrect: * **A. PSGN:** Usually follows a sore throat (2 weeks) or skin infection (4 weeks). While it presents with low C3, it is not associated with Hepatitis C. * **B. Cryoglobulinemia:** Strongly associated with Hepatitis C and low complement (especially C4). It typically presents with a triad of purpura, arthralgia, and weakness (Meltzer’s triad), which is absent here. * **C. MPGN:** This is the most common histological pattern associated with Hepatitis C. It presents with low complement levels. In many clinical exams, if MPGN and IgA are both options, the presence of low complement favors MPGN/Cryoglobulinemia. #### NEET-PG High-Yield Pearls: * **IgA Nephropathy (Berger’s Disease):** Most common GN worldwide. Characterized by **synpharyngitic hematuria** (occurs within 1-2 days of URI) . Complement levels are **Normal**. * **Hepatitis C Associations:** Most commonly associated with **Type II Mixed Cryoglobulinemia** and **MPGN**. * **Low Complement GNs:** Remember the mnemonic **"PMS"** — **P**SGN, **M**PGN, and **S**LE (Lupus Nephritis). * **Complement in IgA:** If a question specifies IgA Nephropathy but mentions low complement, look for co-existing conditions, though in standard textbook definitions, IgA is a "normal complement" GN.

Question 58: The triad of hematuria, hypertension, and edema is a characteristic feature of which condition?

A. Acute Glomerulonephritis (Correct Answer)
B. Acute Pyelonephritis
C. Chronic Glomerulonephritis
D. Renal cell carcinoma

Explanation: **Explanation:** The classic triad of **hematuria, hypertension, and edema** defines **Nephritic Syndrome**, which is the hallmark clinical presentation of **Acute Glomerulonephritis (AGN)** [1]. 1. **Why Option A is Correct:** AGN (most commonly Post-Streptococcal Glomerulonephritis) involves immune-mediated inflammation of the glomeruli. This leads to: * **Hematuria:** Damage to the glomerular capillary wall allows RBCs to leak into the urine (often presenting as "cola-colored" urine with RBC casts) [1]. * **Hypertension & Edema:** A decrease in the Glomerular Filtration Rate (GFR) leads to salt and water retention, causing volume expansion and periorbital/peripheral edema [1]. 2. **Why other options are incorrect:** * **B. Acute Pyelonephritis:** This is an upper urinary tract infection characterized by the triad of **fever, loin pain (flank pain), and pyuria/bacteriuria**. It does not typically cause hypertension or significant edema. * **C. Chronic Glomerulonephritis:** While it can present with these features, it is characterized by long-term progressive renal scarring, small shrunken kidneys on ultrasound, and features of uremia rather than an acute nephritic onset. * **D. Renal Cell Carcinoma:** The classic triad for RCC is **hematuria, flank pain, and a palpable abdominal mass**. Hypertension may occur as a paraneoplastic syndrome, but generalized edema is not a primary feature. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause of AGN in children:** Post-Streptococcal Glomerulonephritis (PSGN) [1]. * **Urinary finding:** Presence of **RBC casts** is pathognomonic for glomerular bleeding. * **Complement levels:** C3 is characteristically **low** in PSGN and Lupus Nephritis but normal in IgA Nephropathy [1]. * **Nephrotic vs. Nephritic:** Remember that Nephrotic syndrome is defined by massive proteinuria (>3.5g/day) and severe edema, but usually lacks significant hematuria or hypertension [1].

Question 59: Presence of which of the following in the urine is diagnostic of glomerular injury?

A. Bright red cells
B. 20% dysmorphic RBCs (Correct Answer)
C. 100 RBCs per high power field
D. Beta-2 microglobulin

Explanation: The presence of **dysmorphic Red Blood Cells (RBCs)** in the urine is a hallmark of **glomerular bleeding** [1]. When RBCs pass through the damaged glomerular basement membrane (GBM) and travel through the varying osmotic gradients of the renal tubules, they undergo mechanical and chemical stress. This results in distorted shapes, such as blebs, protrusions, or fragmented membranes [1]. * **Why Option B is correct:** While various thresholds exist, the presence of **>20% dysmorphic RBCs** (or specifically **>5% Acanthocytes/G1 cells**) is highly specific for a glomerular source of hematuria (e.g., Glomerulonephritis). Acanthocytes, which are ring-shaped RBCs with vesicle-like protrusions, are the most reliable markers [1]. * **Why Option A is incorrect:** Bright red cells (isomorphic RBCs) usually indicate **non-glomerular bleeding** from the lower urinary tract (ureters, bladder, or urethra), such as from stones, trauma, or malignancy [1]. * **Why Option C is incorrect:** The quantity of RBCs (100 RBCs/HPF) indicates the severity of hematuria but does not localize the site of injury. Both glomerular and post-glomerular pathologies can cause high-grade hematuria [1]. * **Why Option D is incorrect:** Beta-2 microglobulin is a low-molecular-weight protein. Increased levels in the urine are a marker of **tubular injury** (proximal tubule dysfunction), not glomerular injury. **High-Yield Clinical Pearls for NEET-PG:** * **Red Cell Casts:** These are 100% pathognomonic for glomerular hematuria [1]. * **Acanthocytes:** Specifically, the "Mickey Mouse" appearance of RBCs is the most specific type of dysmorphic cell for glomerulonephritis. * **Glomerular vs. Non-Glomerular:** Glomerular hematuria is often associated with significant proteinuria (>500 mg/day) and a "smoky" or "cola-colored" urine appearance, whereas non-glomerular hematuria often presents with blood clots [1].

Question 60: Which of the following conditions is typically associated with hyperphosphatemia?

A. Chronic renal failure (Correct Answer)
B. Rickets
C. Prolonged phosphate intake
D. Osteitis fibrosa cystica

Explanation: ### Explanation **Correct Answer: A. Chronic renal failure** **Mechanism:** The kidney is the primary organ responsible for phosphate excretion. In **Chronic Renal Failure (CRF)**, the decline in the Glomerular Filtration Rate (GFR) leads to a proportional decrease in the filtered load of phosphate [2]. Once the GFR falls below **25–30 mL/min**, the remaining nephrons can no longer compensate for the phosphate load, leading to **hyperphosphatemia** [1]. This phosphate retention is a key driver of secondary hyperparathyroidism and Renal Osteodystrophy [1]. **Analysis of Incorrect Options:** * **B. Rickets:** This condition is characterized by a deficiency in Vitamin D or calcium, or a resistance to Vitamin D action. It typically presents with **hypophosphatemia** (low phosphate) due to decreased intestinal absorption and secondary hyperparathyroidism, which increases renal phosphate excretion [3]. * **C. Prolonged phosphate intake:** In individuals with normal renal function, the kidneys have a massive capacity to excrete excess dietary phosphate. Therefore, prolonged intake rarely leads to sustained hyperphosphatemia unless there is underlying renal impairment. * **D. Osteitis fibrosa cystica:** This is a bone manifestation of severe hyperparathyroidism. While it is often *caused* by the hyperphosphatemia of renal failure, the bone disease itself is a result of high PTH levels [1]. In primary hyperparathyroidism (where this is classically seen), phosphate levels are actually **low** due to the phosphaturic effect of PTH [3]. **NEET-PG High-Yield Pearls:** * **Fibroblast Growth Factor 23 (FGF-23):** This is the earliest marker of phosphate metabolism derangement in CKD; it rises before phosphate levels do, to promote urinary phosphate excretion [1], [2]. * **Phosphate Binders:** In CRF, hyperphosphatemia is managed using binders like **Sevelamer** (non-calcium based) or Calcium acetate. * **The "Trade-off" Hypothesis:** Hyperphosphatemia lowers ionized calcium, which triggers PTH release. While PTH helps normalize phosphate initially, it leads to the "trade-off" of metabolic bone disease [1].

Practice by Chapter

Acute Kidney Injury

Practice Questions

Chronic Kidney Disease

Practice Questions

Glomerular Diseases

Practice Questions

Tubulointerstitial Diseases

Practice Questions

Nephrotic and Nephritic Syndromes

Practice Questions

Urinary Tract Infections

Practice Questions

Renal Replacement Therapy

Practice Questions

Fluid and Electrolyte Disorders

Practice Questions

Acid-Base Disorders

Practice Questions

Kidney in Systemic Diseases

Practice Questions

Kidney Stones and Obstructive Uropathy

Practice Questions

Hypertension in Kidney Disease

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free

Nephrology — MCQs

Nephrology — MCQs

On this page

Practice by Chapter

Want unlimited practice?